Tandem Diabetes Care (TNDM) Deferred Taxes (2019)
Tandem Diabetes Care (TNDM) reported Deferred Taxes of -$25000.0 for Q4 2019.
Tandem Diabetes Care (TNDM) Deferred Taxes (2019) Analysis & Trends
Tandem Diabetes Care has reported Deferred Taxes for 1 years, with the latest figure at -$25000.0 in Q4 2019.
- For the quarter ending Q4 2019, Deferred Taxes changed N/A year-over-year to -$25000.0; the trailing twelve-month figure through Sep 2021 stood at -$25000.0 (changed N/A YoY), and the FY2020 full-year result was -$2.1 million, down 8404.0% from the prior year.
- Deferred Taxes for Q4 2019 stood at -$25000.0.
- The five-year high for Deferred Taxes was -$25000.0 in Q4 2019, with the low at -$25000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -101.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 300,000.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -16.70 Mn |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -25,000.00 |